Kari Kervinen

15.1k total citations
82 papers, 3.5k citations indexed

About

Kari Kervinen is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Kari Kervinen has authored 82 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Surgery, 30 papers in Cardiology and Cardiovascular Medicine and 26 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Kari Kervinen's work include Diabetes, Cardiovascular Risks, and Lipoproteins (23 papers), Lipoproteins and Cardiovascular Health (20 papers) and Coronary Interventions and Diagnostics (20 papers). Kari Kervinen is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (23 papers), Lipoproteins and Cardiovascular Health (20 papers) and Coronary Interventions and Diagnostics (20 papers). Kari Kervinen collaborates with scholars based in Finland, United Kingdom and Spain. Kari Kervinen's co-authors include Markku J. Savolainen, Y. Antero Kesäniemi, Markku Laakso, Y. Antero Kesäniemi, Tuomo Hänninen, Keijo Koivisto, Matti Vanhanen, Johanna Kuusisto, Leena Mykkänen and Y. Antero Kesäniemi and has published in prestigious journals such as Circulation, Gastroenterology and American Journal of Clinical Nutrition.

In The Last Decade

Kari Kervinen

79 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kari Kervinen Finland 34 1.2k 1.0k 938 726 519 82 3.5k
Jamie Y. Jeremy United Kingdom 40 995 0.8× 1.2k 1.1× 807 0.9× 937 1.3× 826 1.6× 150 4.6k
Andrea Semplicini Italy 35 612 0.5× 758 0.7× 1.0k 1.1× 1.1k 1.5× 1.4k 2.7× 165 4.0k
Kishio Nanjo Japan 29 1.3k 1.0× 910 0.9× 1.6k 1.7× 687 0.9× 1.2k 2.2× 91 4.4k
Goji Hasegawa Japan 39 1.1k 0.9× 991 1.0× 1.2k 1.3× 885 1.2× 1.1k 2.1× 190 5.5k
Andreas Andersen Denmark 28 564 0.5× 467 0.5× 1.7k 1.9× 1.1k 1.5× 625 1.2× 71 4.3k
H. Radner Austria 26 401 0.3× 575 0.6× 527 0.6× 807 1.1× 636 1.2× 65 3.6k
Ken Sugimoto Japan 32 448 0.4× 1.0k 1.0× 568 0.6× 1.1k 1.5× 915 1.8× 132 3.8k
Pingjin Gao China 40 879 0.7× 710 0.7× 758 0.8× 1.7k 2.3× 1.6k 3.2× 213 5.1k
Masaki Mogi Japan 43 568 0.5× 997 1.0× 1.3k 1.4× 2.1k 2.9× 1.9k 3.7× 179 5.4k
Ingrid M. Garrelds Netherlands 37 655 0.5× 848 0.8× 1.6k 1.7× 2.2k 3.0× 1.2k 2.3× 147 4.4k

Countries citing papers authored by Kari Kervinen

Since Specialization
Citations

This map shows the geographic impact of Kari Kervinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kari Kervinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kari Kervinen more than expected).

Fields of papers citing papers by Kari Kervinen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kari Kervinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kari Kervinen. The network helps show where Kari Kervinen may publish in the future.

Co-authorship network of co-authors of Kari Kervinen

This figure shows the co-authorship network connecting the top 25 collaborators of Kari Kervinen. A scholar is included among the top collaborators of Kari Kervinen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kari Kervinen. Kari Kervinen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mahendiran, Thabo, Frédéric Bouisset, Pim A.L. Tonino, et al.. (2025). Titanium-nitride-oxide-coated vs. drug-eluting stents in acute coronary syndromes: an individual patient data meta-analysis. European Heart Journal. 46(22). 2092–2100.
2.
Sia, Jussi, Kari Kervinen, Matti Niemelä, et al.. (2025). 10-year follow-up of patients with titanium-nitride-oxide-coated stents versus everolimus-eluting stents in acute coronary syndrome. Cardiovascular revascularization medicine. 80. 101–107.
3.
Tonino, Pim A.L., Nico H.J. Pijls, Carlos Collet, et al.. (2020). Titanium-Nitride-Oxide–Coated Versus Everolimus-Eluting Stents in Acute Coronary Syndrome. JACC: Cardiovascular Interventions. 13(14). 1697–1705. 25 indexed citations
4.
Jensen, Lisette Okkels, Saila Vikman, Lisbeth Antonsen, et al.. (2017). Intravascular ultrasound assessment of minimum lumen area and intimal hyperplasia in in-stent restenosis after drug-eluting or bare-metal stent implantation. The Nordic Intravascular Ultrasound Study (NIVUS). Cardiovascular revascularization medicine. 18(8). 577–582. 15 indexed citations
5.
Karjalainen, Pasi P., Wail Nammas, Antti Ylitalo, et al.. (2016). Long-term clinical outcome of titanium-nitride-oxide-coated stents versus everolimus-eluting stents in acute coronary syndrome: Final report of the BASE ACS trial. International Journal of Cardiology. 222. 275–280. 17 indexed citations
6.
Tuomainen, Petri, Antti Ylitalo, Matti Niemelä, et al.. (2012). Five-year clinical outcome of titanium-nitride-oxide-coated bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: Long-term follow-up from the TITAX AMI trial. International Journal of Cardiology. 168(2). 1214–1219. 37 indexed citations
7.
Karjalainen, Pasi P., Antti Ylitalo, Matti Niemelä, et al.. (2009). Two-year follow-up after percutaneous coronary intervention with titanium-nitride-oxide-coated stents versus paclitaxel-eluting stents in acute myocardial infarction. Annals of Medicine. 41(8). 599–607. 24 indexed citations
8.
Karjalainen, Pasi P., Antti Ylitalo, Matti Niemelä, et al.. (2008). Titanium-nitride-oxide coated stents versus paclitaxel-eluting stents in acute myocardial infarction: a 12-months follow-up report from the TITAX AMI trial. EuroIntervention. 4(2). 234–241. 32 indexed citations
9.
Mäkikallio, Timo, Matti Niemelä, Kari Kervinen, et al.. (2008). Coronary angioplasty in drug eluting stent era for the treatment of unprotected left main stenosis compared to coronary artery bypass grafting. Annals of Medicine. 40(6). 437–443. 43 indexed citations
10.
Karvonen, Jarkko, Heikki Kauma, Kari Kervinen, et al.. (2002). Endothelial nitric oxide synthase gene Glu298Asp polymorphism and blood pressure, left ventricular mass and carotid artery atherosclerosis in a population‐based cohort. Journal of Internal Medicine. 251(2). 102–110. 73 indexed citations
11.
Karttunen, Vesa, Georg Alfthan, Leena Hiltunen, et al.. (2002). Risk factors for cryptogenic ischaemic stroke. European Journal of Neurology. 9(6). 625–632. 41 indexed citations
12.
Kervinen, Kari, Asko O. Rantala, Heikki Kauma, et al.. (1999). The role of apolipoprotein E and glucose intolerance in gallstone disease in middle aged subjects. Gut. 44(4). 557–562. 30 indexed citations
13.
Paassilta, Marita, Kari Kervinen, Asko O. Rantala, et al.. (1998). Social alcohol consumption and low Lp(a) lipoprotein concentrations in middle aged Finnish men: population based study. BMJ. 316(7131). 594–595. 39 indexed citations
14.
Kervinen, Kari, Jaakko Kaprio, Markku Koskenvuo, Juhani Juntunen, & Y. Antero Kesäniemi. (1998). Serum lipids and apolipoprotein E phenotypes in identical twins reared apart1. Clinical Genetics. 53(3). 191–199. 8 indexed citations
15.
Rantala, Maire, et al.. (1997). Apolipoprotein E phenotype and diet-induced alteration in blood pressure. American Journal of Clinical Nutrition. 65(2). 543–550. 12 indexed citations
16.
Helkala, E.-L., Keijo Koivisto, Tuomo Hänninen, et al.. (1996). Memory functions in human subjects with different apolipoprotein E phenotypes during a 3-year population-based follow-up study. Neuroscience Letters. 204(3). 177–180. 80 indexed citations
17.
Sarkkinen, Essi, Ursula Schwab, Leo Niskanen, et al.. (1996). The effects of monounsaturated-fat enriched diet and polyunsaturated-fat enriched diet on lipid and glucose metabolism in subjects with impaired glucose tolerance.. PubMed. 50(9). 592–8. 40 indexed citations
18.
Hörkkö, Sohvi, K Huttunen, Kari Kervinen, & Y. Antero Kesäniemi. (1994). Decreased clearance of uraemic and mildly carbamylated low‐density lipoprotein. European Journal of Clinical Investigation. 24(2). 105–113. 59 indexed citations
19.
Kervinen, Kari, Markku J. Savolainen, & Y. Antero Kesäniemi. (1991). A rapid increase in lipoprotein (a) levels after ethanol withdrawal in alcoholic men. Life Sciences. 48(22). 2183–2188. 49 indexed citations
20.
Kesäniemi, Y. Antero, Martti Färkkilâ, Kari Kervinen, et al.. (1987). Regulation of low-density lipoprotein apolipoprotein B levels. American Heart Journal. 113(2). 508–513. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026